- Home
- BXMX vs TLRY Comparison
BXMX vs TLRY Comparison
Compare BXMX & TLRY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | BXMX | TLRY |
|---|---|---|
| Founded | 2004 | N/A |
| Country | United States | Canada |
| Employees | N/A | N/A |
| Industry | Investment Managers | Medicinal Chemicals and Botanical Products |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.5B | 1.2B |
| IPO Year | N/A | 2018 |
Fundamental Metrics
Financial Performance| Metric | BXMX | TLRY |
|---|---|---|
| Price | $14.65 | $9.42 |
| Analyst Decision | | Buy |
| Analyst Count | 0 | 3 |
| Target Price | N/A | ★ $150.00 |
| AVG Volume (30 Days) | 205.6K | ★ 11.1M |
| Earning Date | 01-01-0001 | 01-08-2026 |
| Dividend Yield | ★ 7.24% | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $837,323,000.00 |
| Revenue This Year | N/A | $7.57 |
| Revenue Next Year | N/A | $4.57 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | ★ 0.98 |
| 52 Week Low | $11.75 | $3.51 |
| 52 Week High | $13.75 | $23.20 |
Technical Indicators
Market Signals| Indicator | BXMX | TLRY |
|---|---|---|
| Relative Strength Index (RSI) | 55.55 | 55.25 |
| Support Level | $14.66 | $8.88 |
| Resistance Level | $14.84 | $10.13 |
| Average True Range (ATR) | 0.13 | 0.59 |
| MACD | -0.00 | -0.26 |
| Stochastic Oscillator | 59.57 | 46.71 |
Price Performance
Historical ComparisonAbout BXMX Nuveen S&P 500 Buy-Write Income Fund of Beneficial Interest
Nuveen S&P 500 Buy-Write Income Fund is a diversified closed-ended management investment company based in the United States. Its investment objective is to seek attractive total returns with less volatility. The fund invests its managed assets in a diversified equity portfolio that seeks to substantially replicate price movements of the S&P 500 Index. It also uses an index options of writing (selling) index call options in seeking to moderate the volatility of returns relative to an all-equity portfolio. Its revenue is generated mainly from interest and dividend income.
About TLRY Tilray Brands Inc.
Tilray is a Canadian producer that cultivates and sells medical and recreational cannabis. In 2021, legacy Aphria acquired legacy Tilray in a reverse merger and renamed itself Tilray. The bulk of its sales are in Canada and in the international medical cannabis export market. US exposure comes mainly from alcohol.